There is a need for effective and well-tolerated treatments that can be used in the early stages of dementia. Overall, the evidence suggests that taking a standardized, proprietary ginkgo extract may be an effective intervention for the primary and secondary prevention of cognitive impairment and mild to moderate dementia. To confirm the efficacy in patients with mild dementia, Riepe et al. conducted a meta-analysis.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- EHA 2025
Progress in multiple myeloma
- Interstitial lung diseases
Artificial intelligence improves ILD diagnosis
- Management of patients after alloHCST
ERS/EBMT guideline recommendations on pulmonary cGvHD
- Pyoderma gangraenosum
New study data confirm the validity of the PARACELSUS score
- Progressive multiple sclerosis
New horizons: from BTK inhibitors to remyelination
- Cutaneous and especially facial metastases
Rare manifestations of esophageal carcinoma
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- IMCAS Refresher: Aging Sciences/Plastic Surgery